Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Mar-24 5:26 PM View:  | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 28-Nov-23 4:29 PM View: | Harpoon Therapeutics, Inc. (HARP) | 27-Nov-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 18-May-22 8:21 PM View: | Evolus, Inc. (EOLS) | 18-May-22 | Sale | 52,015 | $12.42 | $646,026.00 | (27%) 193.59K to 141.57K | |
| 18-May-22 8:21 PM View: | Evolus, Inc. (EOLS) | 17-May-22 | Private Sale | 16,189 | $13.92 | $225,354.00 | (8%) 209.78K to 193.59K | |
| 10-Mar-22 7:23 PM View: | Evolus, Inc. (EOLS) | 08-Mar-22 | Private Sale (Planned) | 10,192 | $9.73 | $99,121.30 | (5%) 219.97K to 209.78K | |
| 26-Jan-22 9:03 PM View: | Evolus, Inc. (EOLS) | 24-Jan-22 | Grant | 53,571 | -- | -- | 32% 166.4K to 219.97K | |
| 12-Aug-21 6:45 PM View: | Evolus, Inc. (EOLS) | 10-Aug-21 | Market Sale (Planned) | 14,293 | $11.18 | $159,774.00 | 8% 180.69K to 194.98K | (2%) |
| 01-Feb-21 7:29 PM View: | Evolus, Inc. (EOLS) | 27-Jan-21 | Grant | 90,000 | -- | -- | 99% 90.69K to 180.69K | |
| 26-Jan-21 8:51 PM View: | Evolus, Inc. (EOLS) | 25-Jan-21 | Market Sale (Planned) | 2,699 | $7.46 | $20,134.50 | (3%) 93.39K to 90.69K | |
| 15-May-20 7:59 PM View: | Evolus, Inc. (EOLS) | 13-May-20 | Grant | 40,000 | -- | -- | 75% 53.39K to 93.39K | |
| 24-Jan-20 9:14 PM View: | Evolus, Inc. (EOLS) | 23-Jan-20 | Grant | 26,000 | -- | -- | 95% 27.39K to 53.39K | |
| 31-May-19 7:51 PM View: | Evolus, Inc. (EOLS) | 31-May-19 | Market Sale | 2,612 | $13.53 | $35,352.10 | (9%) 30.0K to 27.39K | 72% |
| 31-May-18 4:15 PM View: | Evolus, Inc. (EOLS) | 29-May-18 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 24-May-18 7:24 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-May-18 | Market Sale (Planned) | 2,874 | $30.25 | $86,924.40 | (4%) 68.37K to 65.5K | 9% |
| 23-Mar-18 9:12 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-Mar-18 | Market Sale (Planned) | 3,431 | $30.85 | $105,839.00 | (5%) 71.8K to 68.37K | 11% |
| 15-Mar-18 8:54 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-18 | Payment of Exercise | 1,152 | $31.65 | $36,460.80 | (2%) 72.95K to 71.8K | 13% |
| 15-Mar-18 8:54 PM View: | Revance Therapeutics, Inc. (RVNC) | 13-Mar-18 | Option Exercise | 25,867 | $8.70 | $225,043.00 | 35% 72.95K to 98.82K | |
| 15-Mar-18 8:54 PM View: | Revance Therapeutics, Inc. (RVNC) | 13-Mar-18 | Market Option Sale (Planned) | 25,867 | $34.50 | $892,412.00 | (26%) 98.82K to 72.95K | 20% |
| 09-Mar-18 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Mar-18 | Option Exercise | 10,000 | $8.70 | $87,000.00 | 14% 72.95K to 82.95K | |
| 09-Mar-18 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Mar-18 | Market Option Sale (Planned) | 10,000 | $32.50 | $325,000.00 | (12%) 82.95K to 72.95K | 15% |
| 09-Mar-18 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 07-Mar-18 | Option Exercise | 10,000 | $8.70 | $87,000.00 | 14% 72.95K to 82.95K | |
| 09-Mar-18 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 07-Mar-18 | Market Option Sale (Planned) | 10,000 | $31.50 | $315,000.00 | (12%) 82.95K to 72.95K | 12% |
| 16-Feb-18 7:45 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-18 | Payment of Exercise | 1,136 | $31.75 | $36,068.00 | (2%) 74.09K to 72.95K | 13% |
| 09-Feb-18 9:16 PM View: | Revance Therapeutics, Inc. (RVNC) | 08-Feb-18 | Grant | 8,125 | -- | -- | 12% 65.97K to 74.09K | |
| 30-Jan-18 9:06 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Jan-18 | Payment of Exercise | 990 | $33.50 | $33,165.00 | (1%) 66.95K to 65.97K | 18% |
| 03-Jan-18 8:27 PM View: | Revance Therapeutics, Inc. (RVNC) | 29-Dec-17 | Acquisition (other) | 443 | $22.99 | $10,185.70 | < 1% 66.51K to 66.95K | |
| 28-Dec-17 8:51 PM View: | Revance Therapeutics, Inc. (RVNC) | 26-Dec-17 | Option Exercise | 17,506 | $8.70 | $152,302.00 | 36% 49.01K to 66.51K | |
| 09-Nov-17 7:46 PM View: | Revance Therapeutics, Inc. (RVNC) | 07-Nov-17 | Option Exercise | 10,000 | $8.70 | $87,000.00 | 20% 49.01K to 59.01K | |
| 09-Nov-17 7:46 PM View: | Revance Therapeutics, Inc. (RVNC) | 07-Nov-17 | Market Option Sale (Planned) | 10,000 | $26.83 | $268,267.00 | (17%) 59.01K to 49.01K | (3%) |
| 16-Oct-17 8:20 PM View: | Revance Therapeutics, Inc. (RVNC) | 12-Oct-17 | Market Sale (Planned) | 11,164 | $26.67 | $297,760.00 | (19%) 60.17K to 49.01K | (3%) |
| 05-Jul-17 9:32 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-17 | Acquisition (other) | 604 | $18.32 | $11,063.80 | 1% 59.57K to 60.17K | |
| 31-May-17 9:01 PM View: | Revance Therapeutics, Inc. (RVNC) | 26-May-17 | Option Exercise | 23,000 | $8.70 | $200,100.00 | 63% 36.57K to 59.57K | |
| 24-May-17 9:14 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-May-17 | Market Sale | 1,793 | $20.20 | $36,212.10 | (5%) 38.36K to 36.57K | (37%) |
| 17-Mar-17 7:24 PM View: | Revance Therapeutics, Inc. (RVNC) | 16-Mar-17 | Payment of Exercise | 1,269 | $19.20 | $24,365.80 | (3%) 39.63K to 38.36K | (44%) |
| 30-Jan-17 9:27 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Jan-17 | Disposition | 1,063 | $20.00 | $21,260.00 | (3%) 40.69K to 39.63K | (38%) |
| 30-Jan-17 9:27 PM View: | Revance Therapeutics, Inc. (RVNC) | 26-Jan-17 | Grant | 10,000 | -- | -- | 33% 30.69K to 40.69K | |
| 05-Jul-16 9:13 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-16 | Acquisition (other) | 749 | $11.56 | $8,658.44 | 3% 29.94K to 30.69K | |
| 23-May-16 8:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 19-May-16 | Payment of Exercise | 1,753 | $17.11 | $29,993.80 | (6%) 31.7K to 29.94K | (43%) |
| 04-Feb-16 4:08 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-16 | Grant | 10,000 | -- | -- | 46% 21.7K to 31.7K | |
| 01-Feb-16 6:55 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Jan-16 | Payment of Exercise | 1,063 | $20.30 | $21,578.90 | (5%) 22.76K to 21.7K | (20%) |
| 04-Jan-16 9:11 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-15 | Acquisition (other) | 339 | $27.00 | $9,153.00 | 2% 22.42K to 22.76K | |
| 02-Jul-15 8:38 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-15 | Acquisition (other) | 633 | $14.16 | $8,963.28 | 3% 21.79K to 22.42K | |
| 21-May-15 6:58 PM View: | Revance Therapeutics, Inc. (RVNC) | 19-May-15 | Payment of Exercise | 1,753 | $25.94 | $45,472.80 | (7%) 23.54K to 21.79K | 6% |
| 30-Jan-15 7:12 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Jan-15 | Grant | 7,290 | -- | -- | 46% 15.98K to 23.27K | |
| 15-Dec-14 6:54 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Dec-14 | Market Purchase | 980 | $17.74 | $17,383.20 | 7% 15.0K to 15.98K | 37% |
| 21-May-14 9:33 PM View: | Revance Therapeutics, Inc. (RVNC) | 19-May-14 | Grant | 14,000 | $32.22 | $451,080.00 | 100% 0 to 14.0K | (24%) |
| 15-Jun-12 4:53 PM View: | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 187,141 | $9.10 | $1,702,980.00 | (100%) 187.14K to 0 | |
| 10-May-12 9:18 PM View: | ISTA Pharmaceuticals Inc. (ISTA) | 08-May-12 | Payment of Exercise | 80,577 | $9.08 | $731,639.00 | (30%) 265.6K to 185.02K | < 1% |
| 10-May-12 9:18 PM View: | ISTA Pharmaceuticals Inc. (ISTA) | 08-May-12 | Option Exercise | 145,813 | $5.02 | $731,653.00 | 122% 119.78K to 265.6K | |
| 09-Feb-12 7:41 PM View: | ISTA Pharmaceuticals Inc. (ISTA) | 08-Feb-12 | Disposition | 1,066 | $8.15 | $8,687.90 | (< 1%) 120.85K to 119.78K | 0% |